AleraCare Holdings, LLC, a US provider of both home and community-based healthcare and pharmacy services for high-need and medically complex populations, received a growth capital investment from St. Cloud Capital.
The amount of the deal was not disclosed.
St. Cloud’s investment, in conjunction with a new ABL facility, was used to refinance existing senior debt as well as fund numerous capital investment initiatives.
Led by Russ Corvese, Chief Executive Officer, AleraCare is the combination of three healthcare companies: MedicoRx Specialty Pharmacy, Vasco Infusion, and VascoRx Specialty Pharmacy.
MedicoRx Specialty Pharmacy is a specialty and home infusion pharmacy servicing the California market.
Vasco Infusion is a physician healthcare practice with several ambulatory infusion centers throughout Arizona and Northern California markets.
VascoRx is a specialty and compounding pharmacy holding licenses in all 50 states.
As AleraCare, it will be able to provide a full spectrum of specialty pharmaceutical services to its current managed care partners, manufacturers, patients, and physicians as well as increase its presence and provide access to its services throughout the western United States.